Daily-use sporicidal disinfectant offers hospitals broad spectrum
efficacy and superior material compatibility compared to bleach
ST. PAUL, Minn.--(BUSINESS WIRE)--
Ecolab introduces OxyCide™ Daily Disinfectant Cleaner, a non-bleach
sporicide developed for daily use in healthcare settings. OxyCide is
proven effective in killing a broad spectrum of harmful bacteria and
viruses, including Clostridium difficile (C. difficile)
spores in three minutes and multi-drug resistant organisms and viruses
in five minutes or less, helping hospitals to reduce the risk of
healthcare-associated infections (HAIs).
Frequently, pathogens travel between environmental surfaces, hands and
ultimately to patients, causing infections. According to the Centers for
Disease Control and Prevention (CDC), approximately 1.7 million patients
contract HAIs in U.S. hospitals every year, of which 14,000 die of C.
difficile infections. Preventing the spread of C. difficile
is particularly difficult because its spores are resistant to standard
disinfectants and can live on hard surfaces for months. According to a
recent study in Journal
of the American Medical Association Internal Medicine, C.
difficile infections cost the healthcare industry $1.5 billion each
year, or approximately $11,285 per case.
"OxyCide is proven to kill 33 different types of bacteria and viruses in
five minutes or less and will help generate efficiency gains and savings
in hospitals by eliminating the need to use multiple solutions on the
different surfaces within operating rooms, patient rooms and common
areas," said Dr. Andy Cooper, vice president of Research, Development &
Engineering at Ecolab. "Using a sporicide everywhere, everyday will help
our customers be more effective in killing C. difficile spores
and other dangerous pathogens."
In a study presented at IDWeek
2012, daily cleaning using OxyCide resulted in a 36.5 percent
reduction of viable bacteria on hospital surfaces compared to other
disinfectants.i OxyCide leaves no visible residue and, unlike
bleach, does not require rinsing. It is non-corrosive on most hard
surfaces, including high-touch objects such as over-bed tables,
bedrails, door handles and bathroom surfaces. In addition, OxyCide's
lockable product cabinet and closed-loop dispensing system offer safer
product handling for staff, helping to reduce the risk of spills by
eliminating the need for manual pouring and mixing.
According to a January 2013 survey from the Association of Professionals
in Infection Control and Epidemiology (APIC), 70 percent of infection
preventionists have adopted additional interventions in their facilities
to address C. difficile since March 2010, however only 42 percent
have seen a decline in their infection rates.ii In addition,
the Centers for Medicare & Medicaid Services have begun requesting C.
difficile infection data from hospitals this year and potentially
could reduce reimbursements related to infections caused by the bacteria.
OxyCide is being featured at the Association for the Healthcare
Environment (AHE) EXCHANGE
2013 meeting in Indianapolis. For more information, visit the OxyCide
Daily Disinfectant Cleaner page on Ecolab.com.
About Ecolab
A trusted partner at more than one million
customer locations, Ecolab (ECL) is the global leader in water, hygiene
and energy technologies and services that protect people and vital
resources. With 2012 sales of $12 billion and 44,000 associates, Ecolab
delivers comprehensive solutions and on-site service to promote safe
food, maintain clean environments, optimize water and energy use and
improve operational efficiencies for customers in the food, healthcare,
energy, hospitality and industrial markets in more than 170 countries
around the world.
For more news and information, visit www.ecolab.com.
Follow us on Twitter @ecolab
or Facebook at facebook.com/ecolab.
i Perkins J, Ferguson J, et. al. Effect
on Patient Room Environmental Bioburden From Use of a Novel Daily-Use
Sporicidal Hard Surface Disinfectant. Poster; IDWeek 2012, San
Diego, CA — October 17-21, 2012.
ii Association of Professionals in Infection Control and
Epidemiology. "2013 CDI Pace of Progress Survey". January 2013. http://cdiff2013.site.apic.org/about-the-conference/cdi-pace-of-progress-survey/.
(ECL-P)
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130916005286/en/
Ecolab Inc.
Roman Blahoski, 651-293-4385
MediaRelations@Ecolab.com
Source: Ecolab Inc.
News Provided by Acquire Media